Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
A rapidly intensifying winter storm is expected to develop into a bomb cyclone this weekend, affecting the Southeast, southern Virginia, and potentially parts of the mid‑Atlantic and New England.
Brent Graves of StockShowAuctions.com takes us to Grayson County to see the damage from a historic winter ice storm and what it will take to rebuild.
Strong blending demand continues to support ethanol use even as production and exports fluctuate.
AFBF Economist Danny Munch shares a closer look at the dairy market and the forces impacting producers today.
Eliza Petry joins the RFD News team with a strong connection to agriculture and a commitment to covering the people and issues that matter most to rural America.
Farm CPA Paul Neiffer helps producers navigate farm program payments and understand the key details farmers need to know.
